MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of marketable
securities
$680,233K
Proceeds from issuance of
common stock related to...
$24,855K
Proceeds from exercise of
common stock options
$3,431K
Proceeds from espp
purchases
$1,493K
Net cash provided by
(used in) investing...
$69,976K
Net cash provided by
financing activities
$29,779K
Canceled cashflow
$610,257K
Net increase
(decrease) in cash, cash...
$28,657K
Canceled cashflow
$71,098K
Purchases of marketable
securities
$607,889K
Purchases of property and
equipment, net
$2,368K
Stock-based compensation
$46,115K
Accrued and other
liabilities
$10,427K
Depreciation and
amortization
$2,700K
Accounts payable
$2,697K
Lease liabilities
$2,557K
Amortization of right of use
assets
$1,893K
Net cash used in
operating activities
-$71,098K
Canceled cashflow
$66,389K
Net loss
-$113,698K
Net amortization
(accretion) of premiums...
$9,976K
Prepaid expenses and
other assets
$7,840K
Contract assets and
liabilities
$5,973K
Back
Back
Cash Flow
source: myfinsight.com
IDEAYA Biosciences, Inc. (IDYA)
IDEAYA Biosciences, Inc. (IDYA)